Evidence map›Paper›PMID 32290539›Full record

ArticleInternational journal of molecular sciences2020

Target of Rapamycin (TOR) Negatively Regulates Ethylene Signals in

Fengping Zhuo, Fangjie Xiong, Kexuan Deng, Zhengguo Li, Maozhi Ren

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. SlMYC2 interacted with theFrontiers in plant science · 2022
    Article
  11. Article
  12. Review
  13. A Tour of TOR Complex Signaling in Plants.Trends in biochemical sciences · 2021
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fengping ZhuoSchool of Life Sciences, Chongqing University, Chongqing 401331, China.
Fangjie XiongSchool of Life Sciences, Chongqing University, Chongqing 401331, China.
Kexuan DengSchool of Life Sciences, Chongqing University, Chongqing 401331, China.
Zhengguo LiSchool of Life Sciences, Chongqing University, Chongqing 401331, China.
Maozhi RenSchool of Life Sciences, Chongqing University, Chongqing 401331, China.
Chongqing University · CN

Funding

China Postdoctoral Science Foundation 2017M622958National Natural Science Foundation of China 31801913 and 31972469the Fundamental and Frontier Research Project of Chongqing cstc2016jcyjA0822
6 · The paper itself

Abstract

Target of rapamycin (TOR) acts as a master regulator in coordination of cell growth with energy and nutrient availability. Despite the increased appreciation of the essential role of the TOR complex in interaction with phytohormone signaling, little is known about its function on ethylene signaling. Here, through expression analysis, genetic and biochemical approaches, we reveal that TOR functions in the regulation of ethylene signals. Transcriptional analysis indicates that TOR inhibition by AZD8055 upregulated senescence- and ethylene-related genes expression. Furthermore, ethylene insensitive mutants like

Indexed as

ArabidopsisArabidopsis ProteinsEthylenesGene Expression Regulation, PlantPhosphatidylinositol 3-KinasesPlant Growth RegulatorsRNA, PlantSignal TransductionArabidopsis ProteinsethyleneEthylenesPhosphatidylinositol 3-KinasesPlant Growth RegulatorsRNA, PlantTOR protein, ArabidopsisArabidopsisethylene signalsgene expressionhypocotyl growth inhibitionTAP46-ACS2/6 interactiontarget of rapamycin

Identifiers

PMID32290539
PMCPMC7215648
OpenAlexW3016247494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.